On mapping the human toxome
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The report by the National Research Council of the US National Academy of Sciences, Toxicity Testing in the 21st Century: A Vision and a Strategy, has prompted a discussion about renewing regulatory toxicology - especially for chemicals - by harnessing in vitro tests, in silico approaches, and testing in lower organisms. The key change is basing the assessments on mechanisms and toxicant modes of action. Identifying pathways of toxicity (PoT), especially on a larger scale, evidently requires omics technologies. When the PoT is known, a test battery allowing higher throughput than the current approach can be constructed. Here, we propose an extension of this concept to mapping the entirety of PoT in humans: the human toxome. Mapping the human toxome will allow us, for the first time, to conclusively identify substances as nontoxic or to identify nontoxic concentrations of substances (i.e., concentrations at which no relevant PoT are triggered). The concept is explained, and opportunities and obstacles are discussed, aiming to promote an initiative which will form the core of a Human Toxicology Project to implement Toxicology for the 21st Century.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
An Introduction to Systems Biology: Design Principles of Biological Circuits
Alon, U. (2006) · doi:10.1201/9781420011432 · Cited by 2,825
Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 1×
“…al., 2009; Hartung, 2009a, 2010b; Hoffmann et al., 2005; Jírová et al., 2010; Knudsen et al., 2009; Kola and Landis, 2004; Martin et al., 2009a,b; Olson et al., 2000; Scott et al., 2010; Snyder and Green, 2001. altex_2011_2_083_093_FFT-Hartung.indd 84 15.5.2011 21:03:26 Uhr Altex 28, 2/11 85 we…”
InfluentialHuman metabolic phenotype diversity and its association with diet and blood pressure
Holmes, E., Loo, R. L., Stamler, J., Bictash, M., Yap, I. K. S., Chan, Q., Ebbels, T., De Iorio, M., Brown, I. J., Veselkov, K. A., et al. (2008) · Nature · doi:10.1038/nature06882 · Cited by 1,054 · cited 1×
“Similarly, metabolic phenotyping was used to identify inter-individual differences linking diet and blood pressure (Holmes et al., 2008).”
MethodTransforming Environmental Health Protection
Collins, F. S., Gray, G. M., & Bucher, J. R. (2008) · Science · doi:10.1126/science.1154619 · Cited by 630
Are In Vitro Tests Suitable for Regulatory Use?
Hartung, T., & Daston, G. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp149 · Cited by 202
Cited by
Toxicity of mercury: Molecular evidence
Yang, L., Zhang, Y., Wang, F., Luo, Z., Guo, S., & Strähle, U. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2019.125586 · Cited by 413
Adverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
Self-citationToxicity testing in the 21st century: progress in the past decade and future perspectives
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., Wambaugh, J. F., Jones, D., Whelan, M., Thomas, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02613-4 · Cited by 383
Self-citationNew approach methodologies in human regulatory toxicology – Not if, but how and when!
Schmeisser, S., Miccoli, A., von Bergen, M., Berggren, E., Braeuning, A., Busch, W., Desaintes, C., Gourmelon, A., Grafström, R., Harrill, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108082 · Cited by 380
Self-citationMaull, E. A., Ahsan, H., Edwards, J., Longnecker, M. P., Navas-Acien, A., Pi, J., Silbergeld, E. K., Styblo, M., Tseng, C.-H., Thayer, K. A., et al. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104579 · Cited by 341
Advances in acute toxicity testing: strengths, weaknesses and regulatory acceptance
Erhirhie, E. O., Ihekwereme, C. P., & Ilodigwe, E. E. (2018) · Interdisciplinary Toxicology · doi:10.2478/intox-2018-0001 · Cited by 329
Markers and Biomarkers of Endothelium: When Something Is Rotten in the State
Goncharov, N. V., Nadeev, A. D., Jenkins, R. O., & Avdonin, P. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9759735 · Cited by 190
“The result of this integration can be a complete mapping of the “toxicity pathways” and creating a “toxome”—a holistic understanding of the mechanisms of action of substances and the relationship between the dose, time, and consequences of exposure [212, 244].”
Why Endocrine Disrupting Chemicals (EDCs) Challenge Traditional Risk Assessment and How to Respond
Futran Fuhrman, V., Tal, A., & Arnon, S. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.12.012 · Cited by 152
Kleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H.-H., Livi, C. B., Madnick, S., et al. (2016) · Scientific Reports · doi:10.1038/srep28994 · Cited by 114
Self-citationValidation and quality control of replacement alternatives - current status and future challenges
Leist, M., Hasiwa, N., Daneshian, M., & Hartung, T. (2012) · Toxicology Research · doi:10.1039/c2tx20011b · Cited by 100
Bouhifd, M. (2015) · ALTEX · doi:10.14573/altex.1502091 · Cited by 69
Use and validation of HT/HC assays to support 21st century toxicity evaluations
Patlewicz, G., Simon, T., Goyak, K., Phillips, R. D., Rowlands, J. C., Seidel, S. D., & Becker, R. A. (2013) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2012.12.008 · Cited by 40
Metadata
- Authors
- Hartung, T.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2011
- Volume
- 28
- Issue
- 2
- Pages
- 83-93
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W156766078
- Cited by
- 132
- References
- 7
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.